newsfilter
← Latest News
PR Newswire·

AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION

EMERYVILLE, Calif., Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM